Source: Annual Congress 2006 - COPD comorbidity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. G. Stoica (Bucharest, Romania). The relationship between depression, medication and stage of the disease in patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 3079

Member's Comments

No comment yet.

Related content which might interest you: Baseline self-reported comorbidity in COPD patients referred for pulmonary rehabilitation (PR) Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Impact of co-morbidities on the rehabilitation outcome in COPD patients Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007 Assessing the multivariate structure and influence of comorbidity in COPD Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 Anxiety and low health status are predictors of exacerbations in patients with obstructive pulmonary disease Source: Annual Congress 2006 - Muscles, training and rehabilitation Year: 2006 The severity of anxiety in COPD patients (pts) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Chronic obstructive pulmonary disease (COPD), comorbid disease, and follow-up hospitalizations in a US cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 COPD and CHF Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations Source: Eur Respir J 2013; 41: 815-823 Year: 2013 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Early discharge for patients with exacerbations of COPD - a real life cohort study Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 Is anxiety and depression a barrier to enrolment in a study in chronic obstructive pulmonary disease (COPD)? Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Prevalence of anxiety and depression in 196 patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Determinants of anxiety and depression among Filipino patients with chronic obstructive pulmonary disease: A multi-center study Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Information on coexisting diseases in patient files in newly referred COPD patients in the KOLibri study Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007 Some gender features of the chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD treatment Year: 2013 Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016